NCT05966714

Brief Summary

In this study, the objective is to compare neonatal cerebral electrical activity within 3 days after birth across different altitude areas using amplitude-integrated electroencephalography (aEEG), and establish reference value for each altitude level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
531

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 14, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2024

Completed
Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

June 14, 2023

Last Update Submit

February 16, 2025

Conditions

Keywords

altitudeneonateAmplitude integrated electroencephalography

Outcome Measures

Primary Outcomes (1)

  • Differences in aEEG indicators in neonates within three days after birth at different altitudes

    aEEG data are acquired by aEEG device. This minimum and maximum value is used as the preliminary smoothing value for that specific time point. Next, a three-order low-pass filter is employed to further refine the preliminary values, and a phase compensation algorithm is applied to restore temporal information and obtain smoothed boundaries.For further analyzing the aEEG data, a total of 63 signal features were extracted to reflect the spectral density aspects by the Auto-Neo-EEG pipeline.

    within three days after birth

Secondary Outcomes (1)

  • Establish reference values for each altitude level

    within three days after birth

Study Arms (2)

Group 1

Lijiang(2500m)

Device: aEEG

Group 2

Shangri-La (3500 m)

Device: aEEG

Interventions

aEEGDEVICE

amplitude-integrated electroencephalography

Group 1Group 2

Eligibility Criteria

Age0 Hours - 72 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Healthy neonates at different altitude levels

You may qualify if:

  • Singleton term infants (gestational age between 37 0/7 and 41 6/7 weeks) born in the participating hospital.
  • Infants appear well as defined by normal vital signs (heart rate ranging from 110 to 180 beats/min, respiratory rate ranging from 30 to 60 breaths/min, temperature ranging from 36.5°C to 37.5°C), absence of signs of illness such as cyanosis, respiratory distress and heart murmur.
  • The mother is permanent residence of the current altitude level and live in the study area for the entire duration of pregnancy.

You may not qualify if:

  • Need for supplemental oxygen or assisted ventilation.
  • Any evidence of intrauterine distress such as meconium-stained amniotic fluid, Apgar score \<7 at 1 or 5 min.
  • Referred to neonatal intensive care unit or neonatology department for any reason other than observation.
  • With major congenital anomaly.
  • Probes cannot be properly placed due to scalp lesions or hematomas.
  • Reject or withdraw from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yangfang Li

Kunming, Yunnan, China

Location

Children Hospital of Fudan University

Shanghai, 201102, China

Location

MeSH Terms

Conditions

Altitude Sickness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2023

First Posted

August 1, 2023

Study Start

June 12, 2023

Primary Completion

June 1, 2024

Study Completion

October 8, 2024

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations